DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,993 filers reported holding DANAHER CORPORATION in Q3 2022. The put-call ratio across all filers is 1.00 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $6,872,000 | -13.0% | 26,605 | -14.6% | 0.24% | -17.8% |
| Q2 2022 | $7,899,000 | +64.2% | 31,154 | +90.0% | 0.29% | +77.0% |
| Q1 2022 | $4,810,000 | +74.1% | 16,400 | +95.2% | 0.16% | +71.9% |
| Q4 2021 | $2,763,000 | -30.7% | 8,400 | -35.8% | 0.10% | -26.2% |
| Q3 2021 | $3,985,000 | -49.3% | 13,090 | -55.3% | 0.13% | -49.0% |
| Q2 2021 | $7,863,000 | +572.1% | 29,300 | +463.5% | 0.26% | +537.5% |
| Q1 2021 | $1,170,000 | -85.2% | 5,200 | -85.4% | 0.04% | -88.8% |
| Q4 2020 | $7,932,000 | +939.6% | 35,709 | +548.2% | 0.36% | +6.2% |
| Q1 2020 | $763,000 | +38050.0% | 5,509 | +27445.0% | 0.34% | +33600.0% |
| Q3 2018 | $2,000 | -50.0% | 20 | -58.3% | 0.00% | -66.7% |
| Q4 2017 | $4,000 | -87.5% | 48 | -87.2% | 0.00% | -87.0% |
| Q3 2017 | $32,000 | -33.3% | 376 | -33.5% | 0.02% | -63.5% |
| Q1 2017 | $48,000 | +23.1% | 565 | +12.5% | 0.06% | +61.5% |
| Q4 2016 | $39,000 | -78.6% | 502 | -72.1% | 0.04% | -81.5% |
| Q2 2016 | $182,000 | – | 1,800 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |